Royal Bank of Canada’s Abiomed Inc ABMD Stock Holding History

Royal Bank of Canada’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-77,477	Closed	-$19M	–	8088
2022 Q3	$19M	Buy	77,477 +7,003	+10%	+$1.89M	0.01%	1093
2022 Q2	$17.4M	Sell	70,474 -3,361	-5%	-$907K	0.01%	1186
2022 Q1	$24.5M	Buy	73,835 +10,119	+16%	+$3.11M	0.01%	1123
2021 Q4	$22.9M	Sell	63,716 -7,230	-10%	-$2.44M	0.01%	1319
2021 Q3	$23.1M	Sell	70,946 -10,920	-13%	-$3.7M	0.01%	1239
2021 Q2	$25.6M	Buy	81,866 +8,131	+11%	+$2.49M	0.01%	1158
2021 Q1	$23.5M	Sell	73,735 -21,283	-22%	-$6.81M	0.01%	1163
2020 Q4	$30.8M	Buy	95,018 +8,827	+10%	+$2.44M	0.01%	962
2020 Q3	$23.9M	Buy	86,191 +359	+0.4%	+$103K	0.01%	984
2020 Q2	$20.7M	Buy	85,832 +12,395	+17%	+$2.49M	0.01%	1016
2020 Q1	$10.7M	Sell	73,437 -4,811	-6%	-$799K	0.01%	1284
2019 Q4	$13.3M	Buy	78,248 +5,615	+8%	+$1.04M	﹤0.01%	1422
2019 Q3	$12.9M	Sell	72,633 -13,945	-16%	-$3.01M	0.01%	1362
2019 Q2	$22.6M	Buy	86,578 +4,956	+6%	+$1.31M	0.01%	1010
2019 Q1	$23.3M	Sell	81,622 -9,537	-10%	-$3.17M	0.01%	966
2018 Q4	$29.6M	Buy	91,159 +9,037	+11%	+$3.14M	0.01%	763
2018 Q3	$36.9M	Sell	82,122 -14,335	-15%	-$5.65M	0.02%	745
2018 Q2	$39.5M	Sell	96,457 -24,605	-20%	-$8.91M	0.02%	671
2018 Q1	$35.2M	Buy	121,062 +2,977	+3%	+$754K	0.02%	734
2017 Q4	$22.1M	Sell	118,085 -7,728	-6%	-$1.44M	0.01%	1070
2017 Q3	$21.2M	Buy	125,813 +3,465	+3%	+$524K	0.01%	1044
2017 Q2	$17.5M	Sell	122,348 -401,498	-77%	-$54M	0.01%	1138
2017 Q1	$65.6M	Sell	523,846 -4,533	-0.9%	-$525K	0.04%	407
2016 Q4	$59.5M	Buy	528,379 +23,025	+5%	+$2.67M	0.03%	451
2016 Q3	$65M	Sell	505,354 -63,904	-11%	-$7.65M	0.04%	403
2016 Q2	$62.2M	Buy	569,258 +2,817	+0.5%	+$280K	0.04%	384
2016 Q1	$53.7M	Sell	566,441 -2,893	-0.5%	-$244K	0.03%	431
2015 Q4	$51.4M	Buy	569,334 +135,179	+31%	+$11.5M	0.03%	439
2015 Q3	$40.3M	Sell	434,155 -119,021	-22%	-$10.5M	0.03%	428
2015 Q2	$36.4M	Sell	553,176 -78,931	-12%	-$5.24M	0.03%	521
2015 Q1	$45.2M	Sell	632,107 -261,159	-29%	-$14.2M	0.03%	429
2014 Q4	$34M	Sell	893,266 -111,246	-11%	-$3.51M	0.02%	580
2014 Q3	$24.9M	Buy	1,004,512 +69,118	+7%	+$1.75M	0.02%	686
2014 Q2	$23.5M	Buy	935,394 +169,321	+22%	+$3.94M	0.02%	710
2014 Q1	$19.9M	Buy	766,073 +764,323	+43,676%	+$21.1M	0.01%	759
2013 Q4	$47K	Sell	1,750 -11,978	-87%	-$296K	﹤0.01%	4920
2013 Q3	$262K	Buy	13,728 +10,128	+281%	+$232K	﹤0.01%	3893
2013 Q2	$78K	Buy	+3,600	New	+$72.4K	﹤0.01%	4434

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's ABMD Position: Q4 2022 in Review

Royal Bank of Canada sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 77,477 shares — an estimated $19M sold.

Royal Bank of Canada first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $65.6M in Q1 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Royal Bank of Canada reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Royal Bank of Canada sold 77,477 Abiomed Inc shares in Q4 2022, an estimated $19M.
Royal Bank of Canada first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Royal Bank of Canada's Abiomed Inc position peaked at $65.6M in Q1 2017.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.